JW Pharmaceutical Corporation (KRX:001060)

Market Cap	735.10B +42.0%
Revenue (ttm)	775.30B +7.8%
Net Income	61.51B -5.4%
EPS	2,534.00 -4.2%
Shares Out	22.89M
PE Ratio	12.71
Forward PE	n/a
Dividend	450.00 (1.45%)
Ex-Dividend Date	Mar 31, 2026

Volume	151,660
Average Volume	68,896
Open	32,650
Previous Close	31,000
Day's Range	31,550 - 33,100
52-Week Range	19,600 - 39,250
Beta	1.18
RSI	55.44
Earnings Date	May 14, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,068
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001060

Financial Performance

In 2025, JW Pharmaceutical's revenue was 775.30 billion, an increase of 7.77% compared to the previous year's 719.38 billion. Earnings were 61.51 billion, a decrease of -5.43%.